Zinc pyrithione (formerly known as OM-1563; AI3-62421; BCJ; BC-J OM1563; Biocut ZP, Finecide ZPT), an ingredient of commercial anti-dandruff shampoos, is an antifungal and antibacterial agent that disrupts membrane transport by blocking the proton pump.

Vonoprazan (TAK-438) is a novel, orally bioavailable and potent P-CAB (potassium-competitive acid blocker) that reversibly inhibits H+/K+, ATPase with IC50 of 19 nM (pH 6.5), controls gastric acid secretion.

Pantoprazole (BY1023; SKF96022; BY-1023; SKF-96022; Protonix), an approved anti-ulcer drug, is a proton pump inhibitor (PPI) used for short-term treatment of erosion and ulceration of the esophagus caused by GERD (gastroesophageal reflux disease).

Lansoprazole (formerly A65006, AG1749; A-65006, AG-1749; trade name Prevacid, Zoton, Agopton, Bamalite, Opiren), a prescription and OTC drug for treatment for heartburn, is a potent and next generation proton-pump inhibitor (PPI) which prevents the stomach from producing gastric acid.

Ilaprazole (IY81149) is an orally bioavailable anti-ulcer agent, acting as a proton pump inhibitor (PPI) and is used in the treatment of dyspepsia, peptic ulcer disease (PUD), gastroesophageal reflux disease (GORD/GERD) and duodenal ulcer.

Tiludronate (Tiludronate disodium; Tiludronic Acid disodium) is a novel and potent bisphosphonate agent which prevents postmenopausal bone loss and is used for treatment of Paget’s disease of bone (osteitis deformans) in human medicine.

Bafilomycin A1 (formerly known as NSC-381866; NSC381866; NSC 381866) is a novel, potent and selective inhibitor of vacuolar H+-ATPase (V-ATPases) with antibacterial activity.

Rabeprazole sodium (LY-307640 sodium) is a novel, potent and 2nd-generation proton pump inhibitor (PPI) that is used as an antiulcer drug.